2seventy bio
2seventy Bio slashes 176 jobs and looks for new CEO after cell therapy setback
Anika Sharma
2seventy bio, the spinoff from bluebird bio, is undergoing significant changes under the leadership of CEO Nick Leschly. The company ...
Trial of 2seventy Bio’s AML cell treatment was put on hold following a death
SG Tylor
Source – 2seventy bio On June 14, 2023, as a result of Seattle Children’s Therapeutics pausing a clinical study of ...
